vs
Esperion Therapeutics, Inc.（ESPR）与MARTIN MIDSTREAM PARTNERS L.P.（MMLP）财务数据对比。点击上方公司名可切换其他公司
MARTIN MIDSTREAM PARTNERS L.P.的季度营收约是Esperion Therapeutics, Inc.的1.1倍（$187.7M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -2.5%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 0.8%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Martin Midstream Partners L.P.是美国中游能源服务提供商，主营原油、天然气液、精炼石油产品及特种化学品的存储、运输、分销与加工服务，主要服务北美能源及工业领域客户。
ESPR vs MMLP — 直观对比
营收规模更大
MMLP
是对方的1.1倍
$168.4M
营收增速更快
ESPR
高出146.3%
-2.5%
两年增速更快
ESPR
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $187.7M |
| 净利润 | — | $3.2M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | 4.1% |
| 净利率 | — | 1.7% |
| 营收同比 | 143.7% | -2.5% |
| 净利润同比 | — | -37.1% |
| 每股收益（稀释后） | $0.32 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRMMLP
| Q1 26 | — | $187.7M | ||
| Q4 25 | $168.4M | $174.2M | ||
| Q3 25 | $87.3M | $168.7M | ||
| Q2 25 | $82.4M | $180.7M | ||
| Q1 25 | $65.0M | $192.5M | ||
| Q4 24 | $69.1M | $171.3M | ||
| Q3 24 | $51.6M | $170.9M | ||
| Q2 24 | $73.8M | $184.5M |
净利润ESPRMMLP
| Q1 26 | — | $3.2M | ||
| Q4 25 | — | $-2.9M | ||
| Q3 25 | $-31.3M | $-8.4M | ||
| Q2 25 | $-12.7M | $-2.4M | ||
| Q1 25 | $-40.5M | $-1.0M | ||
| Q4 24 | — | $-8.9M | ||
| Q3 24 | $-29.5M | $-3.3M | ||
| Q2 24 | $-61.9M | $3.8M |
毛利率ESPRMMLP
| Q1 26 | — | — | ||
| Q4 25 | — | 57.1% | ||
| Q3 25 | — | 55.1% | ||
| Q2 25 | — | 56.5% | ||
| Q1 25 | — | 53.5% | ||
| Q4 24 | — | 58.2% | ||
| Q3 24 | — | 58.5% | ||
| Q2 24 | — | 58.4% |
营业利润率ESPRMMLP
| Q1 26 | — | 4.1% | ||
| Q4 25 | 50.6% | 7.3% | ||
| Q3 25 | -11.4% | 4.1% | ||
| Q2 25 | 8.6% | 8.2% | ||
| Q1 25 | -34.0% | 7.5% | ||
| Q4 24 | -6.4% | 4.0% | ||
| Q3 24 | -31.0% | 7.4% | ||
| Q2 24 | 3.5% | 10.8% |
净利率ESPRMMLP
| Q1 26 | — | 1.7% | ||
| Q4 25 | — | -1.7% | ||
| Q3 25 | -35.9% | -5.0% | ||
| Q2 25 | -15.4% | -1.3% | ||
| Q1 25 | -62.2% | -0.5% | ||
| Q4 24 | — | -5.2% | ||
| Q3 24 | -57.2% | -1.9% | ||
| Q2 24 | -83.9% | 2.0% |
每股收益（稀释后）ESPRMMLP
| Q1 26 | — | — | ||
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.15 | — | ||
| Q2 24 | $-0.33 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | — |
| 总资产 | $465.9M | $537.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRMMLP
| Q1 26 | — | — | ||
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | — |
总债务ESPRMMLP
| Q1 26 | — | — | ||
| Q4 25 | — | $428.0M | ||
| Q3 25 | — | $441.3M | ||
| Q2 25 | — | $427.8M | ||
| Q1 25 | — | $451.4M | ||
| Q4 24 | — | $437.6M | ||
| Q3 24 | — | $469.3M | ||
| Q2 24 | — | $439.4M |
股东权益ESPRMMLP
| Q1 26 | — | — | ||
| Q4 25 | $-302.0M | — | ||
| Q3 25 | $-451.4M | — | ||
| Q2 25 | $-433.5M | — | ||
| Q1 25 | $-426.2M | — | ||
| Q4 24 | $-388.7M | — | ||
| Q3 24 | $-370.2M | — | ||
| Q2 24 | $-344.2M | — |
总资产ESPRMMLP
| Q1 26 | — | $537.1M | ||
| Q4 25 | $465.9M | $522.4M | ||
| Q3 25 | $364.0M | $510.1M | ||
| Q2 25 | $347.1M | $515.6M | ||
| Q1 25 | $324.0M | $533.4M | ||
| Q4 24 | $343.8M | $538.5M | ||
| Q3 24 | $314.1M | $554.8M | ||
| Q2 24 | $352.3M | $535.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | $-6.0M |
| 自由现金流率自由现金流/营收 | — | -3.2% |
| 资本支出强度资本支出/营收 | 0.0% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $27.2M |
8季度趋势，按日历期对齐
经营现金流ESPRMMLP
| Q1 26 | — | — | ||
| Q4 25 | $45.2M | $22.4M | ||
| Q3 25 | $-4.3M | $-1.2M | ||
| Q2 25 | $-31.4M | $30.9M | ||
| Q1 25 | $-22.6M | $-6.0M | ||
| Q4 24 | $-35.0M | $42.2M | ||
| Q3 24 | $-35.3M | $-15.8M | ||
| Q2 24 | $-7.2M | $11.8M |
自由现金流ESPRMMLP
| Q1 26 | — | $-6.0M | ||
| Q4 25 | — | $15.6M | ||
| Q3 25 | — | $-7.9M | ||
| Q2 25 | — | $25.6M | ||
| Q1 25 | — | $-11.9M | ||
| Q4 24 | — | $34.2M | ||
| Q3 24 | $-35.5M | $-25.6M | ||
| Q2 24 | $-7.3M | $-696.0K |
自由现金流率ESPRMMLP
| Q1 26 | — | -3.2% | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | -4.7% | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | -6.2% | ||
| Q4 24 | — | 20.0% | ||
| Q3 24 | -68.7% | -15.0% | ||
| Q2 24 | -9.9% | -0.4% |
资本支出强度ESPRMMLP
| Q1 26 | — | 1.6% | ||
| Q4 25 | 0.0% | 3.9% | ||
| Q3 25 | 0.0% | 4.0% | ||
| Q2 25 | 0.0% | 3.0% | ||
| Q1 25 | 0.0% | 3.1% | ||
| Q4 24 | 0.0% | 4.6% | ||
| Q3 24 | 0.3% | 5.8% | ||
| Q2 24 | 0.1% | 6.8% |
现金转化率ESPRMMLP
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
MMLP
| Specialty products | $61.6M | 33% |
| Transportation * | $52.8M | 28% |
| Other | $46.5M | 25% |
| Terminalling and storage * | $22.4M | 12% |
| Sulfur services | $4.4M | 2% |
